LENZ Therapeutics Inc. (LENZ)
NASDAQ: LENZ
· Real-Time Price · USD
31.96
1.66 (5.48%)
At close: Jun 06, 2025, 3:59 PM
32.57
1.89%
After-hours: Jun 06, 2025, 05:22 PM EDT
5.48% (1D)
| Bid | 29.5 |
| Market Cap | 899.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.74M |
| EPS (ttm) | 0.66 |
| PE Ratio (ttm) | 48.43 |
| Forward PE | -10.62 |
| Analyst | Buy |
| Ask | 32.57 |
| Volume | 457,624 |
| Avg. Volume (20D) | 246,328 |
| Open | 30.89 |
| Previous Close | 30.30 |
| Day's Range | 30.34 - 32.01 |
| 52-Week Range | 14.92 - 38.93 |
| Beta | 0.41 |
About LENZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LENZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LENZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+5.48%
LENZ Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
-2.86%
LENZ Therapeutics shares are trading higher after the company announced the FDA accepted its new drug application for LNZ100 for the treatment of Presbyopia.
